BE Biosol (formerly SGI Pharma / Biological E, Samirpet)

Hyderabad, India

Lyophilized Biologics Fill-Finish Bacteriostatic Water for Injection (BWFI) Terminal Sterilization Monoclonal Antibody Drug Product Vaccines Recombinant Proteins

Program data pending ClinicalTrials.gov matching

60.0

Signal Score

○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: BE Biosol (formerly SGI Pharma / Biological E, Samirpet)

Signal Score: 60.0/100
Quality Compliance: Assessment pending
Headquarters: Hyderabad, India
Modalities: Lyophilized Biologics Fill-Finish, Bacteriostatic Water for Injection (BWFI) Terminal Sterilization, Monoclonal Antibody Drug Product, Vaccines, Recombinant Proteins
Active Programs: No ClinicalTrials.gov matches confirmed
Data Sources: FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By: CDMO Signal — independent CDMO intelligence platform

About BE Biosol (formerly SGI Pharma / Biological E, Samirpet)

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —

No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.

FDA InspectionsNo US records on file

No FDA inspection records found for this manufacturer

Quality score requires FDA inspection data

Operations —

No ClinicalTrials.gov facility matches confirmed for this manufacturer.

Programs — no verified data

Sponsors— no verified data

ModalitiesLyophilized Biologics Fill-Finish, Bacteriostatic Water for Injection (BWFI) Terminal Sterilization, Monoclonal Antibody Drug Product, Vaccines, Recombinant Proteins

No clinical trial matches found for this manufacturer

Operational score requires ClinicalTrials.gov data

Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.

Financial Stability

Profile-based financial assessment

SEC FilingsPrivate company

Private company

Financial assessment: 60.0/100

Capacity

Profile-based capacity assessment

Broad modality coverage (5 modalities)

Frequently Asked Questions About BE Biosol (formerly SGI Pharma / Biological E, Samirpet)

What is BE Biosol (formerly SGI Pharma / Biological E, Samirpet)'s CDMO Signal Score?

BE Biosol (formerly SGI Pharma / Biological E, Samirpet) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.

Evaluating BE Biosol (formerly SGI Pharma / Biological E, Samirpet) for a manufacturing program?

Use the free AI matchmaker to compare BE Biosol (formerly SGI Pharma / Biological E, Samirpet) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.

Find & compare CDMOs →

Represent this organization? Contact us to verify or update this profile.

See all CDMOs in:

Lyophilized Biologics Fill-Finish CDMOs → Monoclonal Antibody Drug Product CDMOs → Recombinant Proteins CDMOs →